Iovance Biotherapeuticsincis A Biopharmaceutical Company Based In San Carloscaliforniaspecializing In Tumor Infiltrating Lymphocytetiltherapies For Advanced Cancersfounded In 2013 And Rebranded In 2017Iovance Focuses On Developing Personalized Cell Therapies That Utilize The Patientae S Immune System To Target Solid Tumorsthe Company Operates Manufacturing And Research Facilities In Philadelphia And Tampa Iovance S Flagship Productamtagvilifileucel Is The First Fda Approved Til Therapy For Unresectable Or Metastatic Melanomaadministered As A One Time Infusionthe Company Also Offers Proleukinaldesleukinto Enhance Til Activityits Pipeline Includes Candidates Targeting Various Cancerssuch As Cervical Cancer And Non Small Cell Lung Cancernsclc Iovance Collaborates With Leading Cancer Research Institutions And Pharmaceutical Companies To Advance Its Clinical Development And Technologythe Company Is Committed To Improving Cancer Treatment Through Innovative Immuno Oncology Solutions
No conferences found for this company.
| Company Name | Iovance Biotherapeutics Inc |
| Country |
United States
|
| Address | 999 Skyway Rd Ste 150 San Carlos California 94070 United States |
| Telephone | Login to View |
| Login to View |
